ogy to
improve patients' lives. He is a Board of Director member for Cardiva, CV
Therapeutics, IDev and Spectranetics. He is a consultant to Boston
Scientific, Cardiva, CV Therapeutics, ev3, FlowMedica, IDev, Possis and
Spectranetics, serves on the speaker's bureau for Abbott, AstraZeneca,
Boston Scientific, Cardiva, Cordis, CV Therapeutics, FlowMedica, Possis,
Spectranetics and Toshiba; and is on the medical/scientific advisory board
for Cardiva, Edwards Lifesciences, FlowMedica, Philips, Spectranetics and
The Medicine Company.
Commenting on his board appointment, Dr. Walker said, "VASAMED, is
committed to bringing the best noninvasive diagnostic hemodynamic products
to the medical community. In practice I have found the SensiLase(R)
System's skin perfusion pressure technology to be a valuable tool to
effectively identify patients with peripheral vascular disease, confirm
clinical outcomes and assist with patient care decisions."
About VASAMED, INC.
VASAMED designs, licenses, manufactures and distributes products that
are used by physicians in their clinic or procedure lab to determine a
patient's hemodynamic and lower extremity arterial health. VASAMED products
and technology are focused on measuring critical cardiovascular and
peripheral information and include SensiLase(R) Skin Perfusion Pressure and
Pulse Volume Recording System to measure capillary perfusion, AcQtrac(TM)
System to monitor heart function, and Tissue Carbon Dioxide Technologies,
featuring the MicroStat(TM) System, to monitor tissue wellness.
'/>"/>SOURCE VASAMED, INC. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
WorldHeart Appoints David Pellone Chief Financial Officer2.
Novo Nordisk Appoints New Leader of North American Business3.
Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility4.
China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.5.
Resonant Medical Appoints New Vice President of Global Sales6.
Response Biomedical appoints S. Wayne Kay Chief Executive Officer7.
Stem Cell Therapy Disappoints Against Rare Kidney Ailment8.
EPI-Q Opens East Coast Office and Appoints Vice President-Business Development9.
President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol10.
Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA11.
Adlyfe Appoints Roxanne Duan as Vice President of Research